Matthew M. Gosling

2015

In 2015, Matthew M. Gosling earned a total compensation of $2M as Senior Vice President and General Counsel at DepoMed, a 42% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$268,637
Option Awards$585,047
Salary$441,577
Stock Awards$718,500
Other$8,686
Total$2,022,447

Gosling received $718.5K in stock awards, accounting for 36% of the total pay in 2015.

Gosling also received $268.6K in non-equity incentive plan, $585K in option awards, $441.6K in salary and $8.7K in other compensation.

Rankings

In 2015, Matthew M. Gosling's compensation ranked 4,687th out of 13,638 executives tracked by ExecPay. In other words, Gosling earned more than 65.6% of executives.

ClassificationRankingPercentile
All
4,687
out of 13,638
66th
Division
Manufacturing
1,714
out of 5,187
67th
Major group
Chemicals And Allied Products
617
out of 1,857
67th
Industry group
Drugs
490
out of 1,531
68th
Industry
Pharmaceutical Preparations
387
out of 1,179
67th
Source: SEC filing on July 14, 2017.

Gosling's colleagues

We found four more compensation records of executives who worked with Matthew M. Gosling at DepoMed in 2015.

2015

James Schoeneck

DepoMed

Chief Executive Officer

2015

August Moretti

DepoMed

Chief Financial Officer

2015

Thadd Vargas

DepoMed

Senior Vice President, Business Development

2015

R Shively

DepoMed

Former Senior Vice President and Chief Commercial Officer

News

You may also like